86.33 BATS BZX Real-Time Price As of 12:59pm ET | ![]() Today’s Change | 66.66 Today|||52-Week Range 97.98 | +1.72% Year-to-Date |
The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Why These Small Cap Biotech ETFs are Soaring Apr 18 / Zacks.com - Paid Partner Content | Is PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) a Hot ETF Right Now? Apr 12 / Zacks.com - Paid Partner Content |
1 month | -2.42% | 3 years | +3.83% | |
3 months | -8.38% | 5 years | +20.49% | |
1 year | +25.13% | Since inception | +14.89% |
Previous close | $86.45 |
Open day’s range | 85.07 – 87.22 |
Net asset value (NAV) | 86.37 (04/24/2018) |
Daily volume | 383,980 |
Average volume (3 months) | 4,855,499 |
XBI | Category | |
---|---|---|
Performance 5-yr return | +20.49% | +14.29% |
Expense Gross exp ratio | 0.35% | 1.30% |
Risk 5 year sharpe ratio | 0.79 | 0.92 |
Net assets | $4.9B | $3.0B |
Average market cap | $3.2B | $10.0B |
Average P/E | -- | 22.2 |
Dividend / Share | -- | 0.30% |
XLV Health Care Select Sector SPDR® Fund |
FHLC Fidelity® MSCI Health Care Index ETF |
VHT Vanguard Health Care Index Fund ETF Shar... |
Healthcare | 100.00% |
Business service | 0.00% |
Consumer goods | 0.00% |
Consumer service | 0.00% |
Energy | 0.00% |
ONCE Spark Therapeutics Inc | 1.63% |
RDUS Radius Health Inc | 1.53% |
REGN Regeneron Pharmaceuticals | 1.52% |
FOLD Amicus Therapeutics Inc | 1.52% |
SRPT Sarepta Therapeutics Inc | 1.50% |
ALKS Alkermes Plc | 1.49% |
AGIO Agios Pharmaceuticals Inc | 1.47% |
UTHR United Therapeutics Corp | 1.47% |
BMRN Biomarin Pharmaceutical Inc | 1.46% |
CELG Celgene | 1.45% |